Fulgent Genetics Stock Investor Sentiment

FLGT Stock  USD 17.48  0.03  0.17%   
Slightly above 56% of Fulgent Genetics' investor base is looking to short. The analysis of overall sentiment of trading Fulgent Genetics stock suggests that many investors are alarmed at this time. Fulgent Genetics' investing sentiment can be driven by a variety of factors including economic data, Fulgent Genetics' earnings reports, geopolitical events, and overall market trends.
  
over six months ago at news.google.com         
Park West Asset Management LLC Buys 79,649 Shares of Fulgent Genetics, Inc. - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Fulgent Genetics Sets New 52-Week Low at 19.85 - Defense World
Google News at Macroaxis
over six months ago at finance.yahoo.com         
What Is Fulgent Genetics, Inc.s Share Price Doing?
Yahoo News
over six months ago at news.google.com         
Disposition of 404 shares by Jian Xie of Fulgent Genetics at 20.65 subject to Rule 16b-3
Google News at Macroaxis
over six months ago at news.google.com         
BNP Paribas Financial Markets Lowers Stock Position in Fulgent Genetics, Inc. - Defense World
Google News at Macroaxis
over six months ago at businesswire.com         
Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FI...
businesswire News
over six months ago at news.google.com         
Disposition of 268 shares by Gao Hanlin of Fulgent Genetics at 20.65 subject to Rule 16b-3
Google News at Macroaxis
over six months ago at news.google.com         
Dimensional Fund Advisors LP Acquires 147,505 Shares of Fulgent Genetics, Inc. - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Trading Advice - Stock Traders Daily
Google News at Macroaxis
over six months ago at businesswire.com         
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate...
businesswire News
over six months ago at www.macroaxis.com         
Disposition of 362 shares by Gao Hanlin of Fulgent Genetics at 21.14 subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Fulgent Genetics, Inc. Shares Sold by Victory Capital Management Inc. - Defense World
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Dell Technologies Bolsters Dell PowerStore with Storage Performance, Resiliency and Efficiency Advan...
Yahoo News
over six months ago at www.macroaxis.com         
Acquisition by Marsh Linda of 8000 shares of Fulgent Genetics subject to Rule 16b-3
Macroaxis News
over six months ago at finance.yahoo.com         
Moffitt and Fulgent Pharma partner on personalised cancer therapies
Yahoo News
Far too much social signal, news, headlines, and media speculation about Fulgent Genetics that are available to investors today. That information is available publicly through Fulgent media outlets and privately through word of mouth or via Fulgent internal channels. However, regardless of the origin, that massive amount of Fulgent data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Fulgent Genetics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Fulgent Genetics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Fulgent Genetics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Fulgent Genetics alpha.

Fulgent Genetics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Fulgent Stock Analysis

When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.